The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 24, 2022

Filed:

Mar. 15, 2013
Applicant:

Mimedx Group, Inc., Marietta, GA (US);

Inventors:

John Daniel, Kennesaw, GA (US);

Randall Spencer, Kennesaw, GA (US);

Brenda Morse, Kennesaw, GA (US);

Thomas J. Koob, Kennesaw, GA (US);

Somaly Sith, Kennesaw, GA (US);

Assignee:

MiMedx Group, Inc., Marietta, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/40 (2006.01); A61L 31/12 (2006.01); A61F 2/02 (2006.01); A61B 17/03 (2006.01); A61F 2/28 (2006.01); A61L 27/50 (2006.01); A61L 27/36 (2006.01); A61L 31/00 (2006.01); A61B 90/00 (2016.01); A61F 2/00 (2006.01); A61B 17/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/50 (2013.01); A61L 27/3604 (2013.01); A61L 27/3675 (2013.01); A61L 27/3687 (2013.01); A61L 31/005 (2013.01); A61B 2017/00884 (2013.01); A61B 2090/0816 (2016.02); A61F 2002/009 (2013.01); A61L 2400/02 (2013.01); A61L 2430/10 (2013.01); A61L 2430/14 (2013.01); A61L 2430/16 (2013.01); A61L 2430/40 (2013.01);
Abstract

Described herein are tissue grafts derived from the placenta that possess good adhesion to biological tissues and are useful in wound healing applications. In one aspect, the tissue graft includes (1) two or more layers of amnion, wherein at least one layer of amnion is cross-linked, (2) two or more layers of chorion, wherein at least one layer of chorion is cross-linked, or (3) one or more layers of amnion and chorion, wherein at least one layer of amnion and/or chorion is cross-linked. In another aspect, the grafts are composed of amnion and chorion cross-linked with one another. In a further aspect, the grafts have one or more layers sandwiched between the amnion and chorion membranes. The amnion and/or the chorion are treated with a cross-linking agent prior to the formation of the graft. The presence of the cross-linking agent present on the graft also enhances adhesion to the biological tissue of interest. Also described herein are methods for making and using the tissue grafts.


Find Patent Forward Citations

Loading…